UPDATE: Cantor Fitzgerald Downgrades Corcept Therapeutics (CORT) to Neutral
Tweet Send to a Friend
(Updated - February 1, 2019 7:59 AM EST)
(updated to add analyst comments)Cantor Fitzgerald analyst Charles Duncan downgraded Corcept ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
(updated to add analyst comments)Cantor Fitzgerald analyst Charles Duncan downgraded Corcept ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
